Inhibition by cycloheximide and dactinomycin of the activation of lipolysis due to growth hormone in white fat cells.
D000273:Adipose Tissue / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D002087:Butyrates / Q000494:pharmacology; D002417:Cattle; D000242:Cyclic AMP / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology*; D003864:Depression, Chemical; D003907:Dexamethasone; D005260:Female; D005938:Glucocorticoids / Q000037:antagonists & inhibitors / Q000494:pharmacology; D013006:Growth Hormone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007016:Hypophysectomy; D050356:Lipid Metabolism; D008660:Metabolism / Q000187:drug effects; D009638:Norepinephrine / Q000494:pharmacology; D010902:Pituitary Gland / Q000502:physiology; D051381:Rats; D013217:Starvation; D013268:Stimulation, Chemical; D013806:Theophylline / Q000494:pharmacology; D014599:Uterus / Q000187:drug effects / Q000378:metabolism
D002087:Butyrates; D005938:Glucocorticoids; D003609:Dactinomycin; D003907:Dexamethasone; D013006:Growth Hormone; D003513:Cycloheximide; D013806:Theophylline; D000242:Cyclic AMP; D009638:Norepinephrine